HNHacker News
TopNewBestAskShowJobs

mchakravarti7

5 karma · joined February 14, 2017

submissionscomments
mchakravarti7··on Launch HN: Coinrule (YC S21) – Automated Trading Made Easy
Hi! This is very interesting - I had a question but more so on the business side. I don't know much about finance, but what made you decide on a fixed fee pricing model than a take rate model like a hedge fund.
mchakravarti7··on Show HN: Flock – Create gift registries for any occasion
Hi all, I built Flock as a way to learn web development over the past few weeks. I've always struggled to figure out what I should gift my friends, and at the same time, there's also way too many things that I like as I browse through social media/the internet on any given day.

I attempted to solve these problems in one go by building Flock, where you can create wishlists from any items on the internet (i.e. you don't have to create a separate wishlist for Amazon, Best Buy items, etc.) for any (or no) occasion. Once you create a wishlist, you can then share it with family and friends, and they can contribute towards your wishlist GoFundMe style!

Here's my wishlist: https://myflock.app/@mohnish

This is the first time I've actually built and shipped something from scratch by myself. I'd love feedback on the design/technicality, and even take feature requests if you have any!

I built this using Node and React, and it is hosted on Firebase for now.

mchakravarti7··on Ask HN: For repeat applicants to YC, how should you measure the progress?
The amount of work/effort put in will have translated to something that's more easily quantifiable/measurable like growth (what kind differs from company to company), improvement in product or even the team. Agree with tzm -- you probably know best about what metrics you'd want to share in that response
mchakravarti7··on Ask HN: How can international students start a startup in US?
There are VC firms that can help you work on an H1B, or even make you an employee in the short term. There's also programs in MA where an university can employ you on an H1B and let you work on your startup. I believe UMass Boston's VDC program is one. OPT is a completely valid option too (source: know a ton of people who have used this and have extensively spoken to attorneys about it)
mchakravarti7··on Ask HN: How can international students start a startup in US?
You can use OPT, but would suggest not to so so because it will have implications on how long you can stay in the US after graduating. CPT is another option if your college allows you to use it. Post-graduation, OPT, H1-B, B1/B2 and O1 are all viable options of varying difficulty
mchakravarti7··on Ask HN: I would like to register a hardware startup in Delaware
There isn't really any benefit to incorporating in both places. If you incorporate in the US and in EU, you will have to pay taxes in both places. Unless you are raising a round and a VC insists on incorporating in the US, it will not make sense to register in both places.

There are lots of benefits to registering in DE compared to some other states in the US, but I'm unsure of any benefits compared to incorporating in the region you are based out of.

I'd suggest talking to an attorney and learning more about this before incorporating. Jared Stark (http://starkbusinesslaw.com/) helped us incorporate and is really helpful

mchakravarti7··on Post incorporation things to take care of while using Stripe Atlas
yes I emailed them, but I was wondering if there's anybody over here who could answer my question too
mchakravarti7··on Michael Seibel, CEO of YC, is doing an AMA
Hi Michael, thanks for the AMA. When you evaluate an early stage biotech startup, what would you say is the most important thing that you look for? - clinically validated products, or a solid long term business model?

With Trump picking Scott Gottlieb to be the next FDA commissioner, the FDA approval process is expected to get more lenient. Would you say that YC (or investors in general) would be open to take more risks with high tech startups that do not have a clinically validated product as of now?

One more question - Given that the FDA process takes a lot of time, quite a few biotech companies often get acquired or merged with bigger companies that can afford to do so, without ever having actually gotten their product out on the market. Would you say that you look at the company's potential return in that sense when you evaluate startups? I'm not entirely sure if this question makes sense, so let me know if you want me to clarify!